Literature DB >> 33902814

An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk.

Torsten Dahlén1,2, Mark Clements3, Jingcheng Zhao2, Martin L Olsson4, Gustaf Edgren2,5.   

Abstract

Background: There are multiple known associations between the ABO and RhD blood groups and disease. No systematic population-based studies elucidating associations between a large number of disease categories and blood group have been conducted.
Methods: Using SCANDAT3-S, a comprehensive nationwide blood donation-transfusion database, we modeled outcomes for 1217 disease categories including 70 million person-years of follow-up, accruing from 5.1 million individuals.
Results: We discovered 49 and 1 associations between a disease and ABO and RhD blood groups, respectively, after adjustment for multiple testing. We identified new associations such as a decreased risk of kidney stones and blood group B as compared to blood group O. We also expanded previous knowledge on other associations such as pregnancy-induced hypertension and blood groups A and AB as compared to blood group O and RhD positive as compared to negative. Conclusions: Our findings generate strong further support for previously known associations, but also indicate new interesting relations. Funding: Swedish Research Council.
© 2021, Dahlén et al.

Entities:  

Keywords:  ABO blood group; RhD blood group; agnostic; all disease; epidemiology; global health; medicine; none

Year:  2021        PMID: 33902814     DOI: 10.7554/eLife.65658

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  7 in total

1.  Country-level factors dynamics and ABO/Rh blood groups contribution to COVID-19 mortality.

Authors:  Alfonso Monaco; Ester Pantaleo; Nicola Amoroso; Loredana Bellantuono; Alessandro Stella; Roberto Bellotti
Journal:  Sci Rep       Date:  2021-12-31       Impact factor: 4.379

2.  Human exposome assessment platform.

Authors:  Roxana Merino Martinez; Heimo Müller; Stefan Negru; Alex Ormenisan; Laila Sara Arroyo Mühr; Xinyue Zhang; Frederik Trier Møller; Mark S Clements; Zisis Kozlakidis; Ville N Pimenoff; Bartlomiej Wilkowski; Martin Boeckhout; Hanna Öhman; Steven Chong; Andreas Holzinger; Matti Lehtinen; Evert-Ben van Veen; Piotr Bała; Martin Widschwendter; Jim Dowling; Juha Törnroos; Michael P Snyder; Joakim Dillner
Journal:  Environ Epidemiol       Date:  2021-12-03

3.  ABO and RhD blood group are not associated with mortality and morbidity in critically ill patients; a multicentre observational study of 29 512 patients.

Authors:  Thomas Kander; Martin F Bjurström; Attila Frigyesi; Magnus Jöud; Caroline U Nilsson
Journal:  BMC Anesthesiol       Date:  2022-04-02       Impact factor: 2.217

4.  Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes.

Authors:  Ulf Ribacke; Mats Wahlgren; Pontus Hedberg; Madle Sirel; Kirsten Moll; Mpungu Steven Kiwuwa; Petter Höglund
Journal:  Malar J       Date:  2021-11-18       Impact factor: 2.979

5.  Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus.

Authors:  Nollaig M Bourke; Darragh Duffy; Cliona O'Farrelly; Jamie A Sugrue; Megan Smith; Celine Posseme; Bruno Charbit
Journal:  Genes Immun       Date:  2022-04-15       Impact factor: 4.248

6.  The Clinical Utility of ABO and RHD Systems as Potential Indicators of Health Status, a Preliminary Study in Greek Population.

Authors:  Evgenia Lymperaki; Evangelia Stalika; George Tzavelas; Efthymia Tormpantoni; Diana Samara; Eleni Vagdatli; Ioannis Tsamesidis
Journal:  Clin Pract       Date:  2022-06-07

7.  ABO, secretor, and Lewis carbohydrate histo-blood groups are associated with autoimmune neutropenia of early childhood in Danish patients.

Authors:  Kirstine Kløve-Mogensen; Rudi Steffensen; Tania Nicole Masmas; Andreas Glenthøj; Thure Mors Haunstrup; Paul Ratcliffe; Petter Höglund; Henrik Hasle; Kaspar René Nielsen
Journal:  Transfusion       Date:  2022-07-06       Impact factor: 3.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.